Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review. Indian J Pharm Drug Studies [Internet]. 2023 Dec. 6 [cited 2024 Nov. 22];1(3):73-8. Available from: https://mansapublishers.com/index.php/ijpds/article/view/3575